Clinical Trial Update: A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects [Phase 2]

View source ↗

Summary

Phase IIb study evaluating a long-acting intramuscular regimen of cabotegravir for maintenance of virologic suppression in HIV-1 infected ART-naive adults after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• abacavir/lamivudine (abacavir/lamivudine)
• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-08-31